Shanghai - Delayed Quote CNY

Micro-Tech (Nanjing) Co.,Ltd (688029.SS)

Compare
66.11
+1.09
+(1.68%)
At close: 3:00:03 PM GMT+8
Loading Chart for 688029.SS
DELL
  • Previous Close 65.02
  • Open 64.91
  • Bid 66.07 x --
  • Ask 66.11 x --
  • Day's Range 64.52 - 66.99
  • 52 Week Range 55.38 - 89.92
  • Volume 1,982,822
  • Avg. Volume 2,529,912
  • Market Cap (intraday) 12.419B
  • Beta (5Y Monthly) 0.22
  • PE Ratio (TTM) 22.49
  • EPS (TTM) 2.94
  • Earnings Date --
  • Forward Dividend & Yield 1.50 (2.31%)
  • Ex-Dividend Date Oct 11, 2024
  • 1y Target Est --

Micro-Tech (Nanjing) Co.,Ltd researches, develops, manufactures, and sells minimally invasive medical devices to hospitals and clinics worldwide. It offers micro-tech endoscopy gastroenterology devices, such as biliary (longwire), biliary (shortwire), biopsy, dilation and hemostasis products, EUS, nitinol stents, resection products, retrieval devices, and accessories; and pulmonology products, such as airway stents, biopsy, dilation balloons, retrieval devices, and accessories. The company also offers OEM/ODM services. Micro-Tech (Nanjing) Co.,Ltd was founded in 1999 and is based in Nanjing, China.

www.micro-tech.com.cn

2,404

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 688029.SS

View More

Performance Overview: 688029.SS

Trailing total returns as of 1/13/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

688029.SS
4.44%
SSE Composite Index
7.24%

1-Year Return

688029.SS
22.90%
SSE Composite Index
9.67%

3-Year Return

688029.SS
48.20%
SSE Composite Index
12.14%

5-Year Return

688029.SS
43.61%
SSE Composite Index
2.21%

Compare To: 688029.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 688029.SS

View More

Valuation Measures

As of 1/10/2025
  • Market Cap

    12.21B

  • Enterprise Value

    10.74B

  • Trailing P/E

    22.12

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.55

  • Price/Book (mrq)

    3.27

  • Enterprise Value/Revenue

    4.01

  • Enterprise Value/EBITDA

    16.39

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    20.55%

  • Return on Assets (ttm)

    8.13%

  • Return on Equity (ttm)

    15.29%

  • Revenue (ttm)

    2.68B

  • Net Income Avi to Common (ttm)

    550.49M

  • Diluted EPS (ttm)

    2.94

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.52B

  • Total Debt/Equity (mrq)

    1.07%

  • Levered Free Cash Flow (ttm)

    412.6M

Research Analysis: 688029.SS

View More

People Also Watch